OpportunityAnalyzer Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Research Report On Researchmoz.us

ResearchMoz.us include new market research report "OpportunityAnalyzer Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update" to its huge collection of research reports.Browse All GlobalData Reports @http://www.researchmoz.us/publisher/globaldata-1.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
ResearchMoz

ResearchMOZ

Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

Albany,New York (PRWEB) April 07, 2014

Researchmoz presents this most up-to-date research on"OpportunityAnalyzer Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update".The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

Opportunity Analyzer report, OpportunityAnalyzer Nonalcoholic Steatohepatitis (NASH) Opportunity Analysis and Forecasts to 2017 Event-Driven Update. The NASH market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfits PPAR agonist, GFT505 and Intercept Pharmaceuticals/Dainippon Sumitomo Pharmas FXR agonist, Obeticholic Acid. These compounds will race to be the first approved therapy thus claiming first in class.

Browse Full Report With TOC At : http://www.researchmoz.us/opportunityanalyzer-nonalcoholic-steatohepatitis-nash-opportunity-analysis-and-forecasts-to-2017-event-driven-update-report.html

Scope

Overview of NASH, including epidemiology, etiology, symptoms, diagnosis, pathology and disease management.

Analysis of the current and future market competition in the global NASH therapeutics market.

Pipeline analysis: comprehensive data split across Phase II/IIb, emerging trends and mechanisms of action under development, including: oral Proliferator Activated Receptor alpha, delta (PPARa,d) agonist, oral Farnesoid X Receptor (FXR) agonist, subcutaneous Lysyl Oxidase-Like 2 (LOXL2) inhibitor and subcutaneous Glucagon-like Peptide-1 (GLP-1) agonist.

Annualized NASH therapeutics market forecast, annual cost of therapy and treatment usage pattern data from 2012-2017.

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Key topics covered include strategic clinical and commercial benchmarking assessment of the pipeline and standard of care, market outlook, R&D strategies, and unmet needs for the NASH therapeutics market.

Market Research Healthcare Related Reports :

Smoking Cessation and Nicotine De-addiction Products Market http://www.researchmoz.us/smoking-cessation-and-nicotine-de-addiction-products-market-nicotine-gums-patches-lozenges-inhalers-sprays-sublingual-tablets-zyban-chantixchampix-e-cigarettes-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html

This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW). Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

Prenatal and New-born Genetic Testing Market http://www.researchmoz.us/prenatal-and-new-born-genetic-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html

Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests and maternal serum screening.Geographically, the report segments the global prenatal and newborn genetic testing market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type and geographic region, along with their sub-segments (if any). The prenatal and newborn genetic testing market report also provides compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.

For More Healthcare Related Reports Visit @ http://www.researchmoz.us/healthcare-market-reports-56.html

Reasons to buy

Develop business strategies and perform superior market quantification analysis by
Understanding the trends shaping and driving the global NASH Therapeutics market.
Understanding treatment preferences of physicians in disease state and across treatment flow.
Accessing market sizing, forecasts and quantified growth opportunities in the global NASH Therapeutics market till 2017.
Quantifying patient population in the global NASH Therapeutics market to better design product pricing & launch plans.
Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape by
Performing benchmarking analysis and growth opportunities against currently marketed products.
Identifying market entry points based on safety, efficacy, and pricing parameters.
Assessing competitiveness of products in market by understanding the strength and weakness of current competition.
Develop and design your in-licensing and out-licensing strategies by
Taking a comprehensive look of at the disease pipeline and identifying most promising paradigm shifting products.
Assessing strength of pipeline based on first in class and lifecycle management of products.
Analyze the potential impact of novel oral therapies such as Genfits GFT505 on the NASH treatment paradigm.
Track drug sales in the global NASH Therapeutics market from 2012 to 2017.
Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.
Whats the next big thing in the global NASH Therapeutics market landscape? Identify, understand, and capitalize.

Browse All Category Wise Research Reports @ http://www.researchmoz.us/category.html

About Us:

ResearchMoz is the one stop online destination to find and buy market research reports. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets.

Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

Contact Us:
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
http://www.researchmoz.us
Blog: http://medicaldevicesmarket.blogspot.com/
wordpress : http://marketresearchtopix.wordpress.com